World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development

Mehand, Massinissa Si; Millett, Piers; Al-Shorbaji, Farah; Roth, Cathy; Kieny, Marie Paule; Murgue, Bernadette

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development

Published Date:

Sep 2018

Source:

Emerg Infect Dis. 24(9).

Language:

English

[PDF-1.04 MB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Mehand, Massinissa Si ; Millett, Piers ; Al-Shorbaji, Farah ; Roth, Cathy ; Kieny, Marie Paule ; ... More ▼

Description:

The World Health Organization R&D Blueprint aims to accelerate the availability of medical technologies during epidemics by focusing on a list of prioritized emerging diseases for which medical countermeasures are insufficient or nonexistent. The prioritization process has 3 components: a Delphi process to narrow down a list of potential priority diseases, a multicriteria decision analysis to rank the short list of diseases, and a final Delphi round to arrive at a final list of 10 diseases. A group of international experts applied this process in January 2017, resulting in a list of 10 priority diseases. The robustness of the list was tested by performing a sensitivity analysis. The new process corrected major shortcomings in the pre-R&D Blueprint approach to disease prioritization and increased confidence in the results.

Subject:

[+]

Pubmed ID:

30124424

Pubmed Central ID:

PMC6106429

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	17-1427-Techapp-s3.pdf	application/pdf
	17-1427-Techapp-s4.pdf	application/pdf
	17-1427-Techapp-s5.pdf	application/pdf
	17-1427-Techapp-s6.pdf	application/pdf
	17-1427.nxml	text/xml
	17-1427-F1.gif	image/gif
	17-1427-F1.jpg	image/jpeg
	17-1427-F2.gif	image/gif
	17-1427-F2.jpg	image/jpeg
	17-1427-F3.gif	image/gif
	17-1427-F3.jpg	image/jpeg
	17-1427-Techapp-s1.pdf	application/pdf
	17-1427-Techapp-s2.pdf	application/pdf

No Related Documents.

You May Also Like:

Databases for Research and Development

Personal Author:

Head, Michael G.

Published Date:

October 2019

Source:

Emerg Infect Dis. 25(10):1996

File Type:

[PDF - 287.04 KB]
Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines

Personal Author:

Bhadelia, Nahid; Sauer, Lauren; Cieslak, Theodore J.; Davey, Richard T.; McLellan, Susan; Uyeki, Timothy M.; Kortepeter, Mark G.;

Published Date:

2019 Jan/Feb

Source:

Health Secur. 17(1):46-53

Description:

Emerging and re-emerging infectious diseases pose growing global public health threats. However, research on and development of medical countermeasures (MCMs) for such pathogens is limited by the sporadic and unpredictable nature of outbreaks, lack o...

File Type:

[PDF - 73.78 KB]
Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type 1 Transmission

Personal Author:

Styles, Claire E.; Hoad, Veronica C.; Denham-Ricks, Paula; Brown, Dianne; Seed, Clive R.;

Published Date:

October 2019

Source:

Emerg Infect Dis. 25(10):1996-1997

File Type:

[PDF - 534.06 KB]
Multisectoral prioritization of zoonotic diseases in Uganda, 2017: A One Health perspective

Personal Author:

Sekamatte, Musa; Krishnasamy, Vikram; Bulage, Lilian; Kihembo, Christine; Nantima, Noelina; Monje, Fred; Ndumu, Deo; Sentumbwe, Juliet; Mbolanyi, Betty; Aruho, Robert; Kaboyo, Winyi; Mutonga, David; Basler, Colin; Paige, Sarah; Barton Behravesh, Casey;

Published Date:

May 01 2018

Source:

PLoS One. 13(5).

Description:

BackgroundZoonotic diseases continue to be a public health burden globally. Uganda is especially vulnerable due to its location, biodiversity, and population. Given these concerns, the Ugandan government in collaboration with the Global Health Securi...

File Type:

[PDF - 1.03 MB]
Development of orphan vaccines: an industry perspective.

Personal Author:

Lang, J.; Wood, S. C.;

Published Date:

1999 Nov-Dec

Source:

Emerg Infect Dis. 5(6):749-756.

Description:

The development of vaccines against rare emerging infectious diseases is hampered by many disincentives. In the face of growing in-house expenditures associated with research and development projects in a complex legal and regulatory environment, mos...

File Type:

[PDF - 78.39 KB]